Smith v. Teva Pharmaceuticals USA, Inc. et al
| Elizabeth N. Smith |
| Teva Women's Health Inc doing business as Teva Women's Health LLC, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Inc and Coopersurgical Inc |
| 1:2021cv02592 |
| June 28, 2021 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 23, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 23 Minute Entry for proceedings held before Judge Leigh Martin May: Status Conference held on 8/23/2021. The Court held its monthly status conference. The parties are directed to file a proposed scheduling order for the September 21st status conference and motion hearing two weeks prior to the hearing. See transcript for details. Associated Cases: 1:20-md-02974-LMM et al.(Court Reporter Montrell Vann)(tcc) |
| Filing 22 Electronic Summons Issued as to Teva Women's Health LLC. (rjc) |
| Filing 21 Electronic Summons Issued as to Teva Pharmaceuticals USA Inc. (rjc) |
| Filing 20 Electronic Summons Issued as to The Cooper Companies Inc. (rjc) |
| Filing 19 Electronic Summons Issued as to TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC.. (rjc) |
| Filing 18 Electronic Summons Issued as to Coopersurgical Inc. (rjc) |
| Filing 17 PROPOSED SUMMONS filed by Elizabeth N. Smith (Attachments: #1 Summons Teva Branded Pharmaceutical Products R&D, Inc., #2 Summons The Cooper Companies, Inc., #3 Summons Teva Pharmaceuticals USA, Inc., #4 Summons Teva Women's Health, LLC)(Kassan, Randi) |
| Filing 16 AMENDED COMPLAINT Short Form Complaint against Coopersurgical Inc, TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC., Teva Pharmaceuticals USA Inc, Teva Women's Health LLC, The Cooper Companies Incwith Jury Demand filed by Elizabeth N. Smith. (Attachments: #1 Civil Cover Sheet)(Kassan, Randi) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. |
Filing 15
Case Management Order Regarding Docket Logistics of Filing of Short Form Complaints, Executed Waivers of Service of Summons of Process, and Notices of Appearance in Individual Cases. Signed by Judge Leigh Martin May on 7/21/2021. Associated Cases: 1:20-md-02974-LMM et al.(rjc)
|
| Filing 14 WAIVER OF SERVICE Returned Executed by Elizabeth N. Smith. The Cooper Companies Inc waiver mailed on 6/30/2021, answer due 8/30/2021. (Kassan, Randi) |
| Filing 13 WAIVER OF SERVICE Returned Executed by Elizabeth N. Smith. Coopersurgical Inc waiver mailed on 6/30/2021, answer due 8/30/2021. (Kassan, Randi) |
| Filing 12 WAIVER OF SERVICE Returned Executed by Elizabeth N. Smith. TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. waiver mailed on 6/30/2021, answer due 8/30/2021. (Kassan, Randi) |
| Filing 11 WAIVER OF SERVICE Returned Executed by Elizabeth N. Smith. Teva Pharmaceuticals USA Inc waiver mailed on 6/30/2021, answer due 8/30/2021. (Kassan, Randi) |
| Filing 10 WAIVER OF SERVICE Returned Executed by Elizabeth N. Smith. Teva Women's Health LLC waiver mailed on 6/30/2021, answer due 8/30/2021. (Kassan, Randi) |
|
Filing 9
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. The below are the orders entered after discussion of these issues at that conference. 1. Leadership structure: After the Court discussed issues concerning the leadership structure with all parties, the Court ORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to their requested leadership structure and team within 7 days of the date of this order. 2. Future status conferences: The Court will hold status conferences once a month. The next six conferences will take place on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021; Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. The Court will send out the zoom links prior to the conferences. The parties will submit a proposed consent agenda 3 business days prior to the conference. The parties will also confer as to the format for presenting issues that require additional explanation. When these are necessary, they should also be filed 3 business days before the conference. 3. Stay of responsive pleading obligations: The Court continues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initial order. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individual cases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motions will later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All parties are to docket future filings only in the MDL case. The case caption should indicate whether any filing applies to all cases or list the individual cases to which it should apply. 6. Electronic service: The Court ORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system. Because all attorneys will then receive electronic copies of documents filed in the MDL, the Court ORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation of service. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shall be obligated to provide service copies of any filings or related orders by U.S. Mail or any other means to attorneys who have not registered with the Court's CM/ECF system. An attorney who is not participating in the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or a certificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The Court GRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures; except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10, 2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8. Case management and initial orders: The parties are ORDERED to confer as to proposed orders for the list found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 2/10/2021.(tmf)
|
| Filing 8 Case transferred in from District of New York Eastern; Case Number 2:21-cv-03205. Original file certified copy of transfer order and docket sheet received. |
| Filing 7 Certified JPMDL Conditional Transfer Order(CTO 26): Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. 1407 to the Northern District of Georgia for the reasons stated in the order of December 16, 2020, and, with the consent of that court, assigned to the Honorable Leigh Martin May. (Florio, Lisa) [Transferred from New York Eastern on 6/28/2021.] |
| Civil Case Terminated. (tmf) |
| Case transferred to Northern District of Georgia. Original file, certified copy of transfer order, and docket sheet sent. ALL FILINGS ARE TO BE MADE IN THE TRANSFER COURT, DO NOT DOCKET TO THIS CASE. (Florio, Lisa) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 6 JPMDL Conditional Transfer Order(CTO 26): Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. 1407 to the Northern District of Georgia for the reasons stated in the order of December 16, 2020, and, with the consent of that court, assigned to the Honorable Leigh Martin May. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Northern District of Georgia. (Florio, Lisa) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 5 SUMMONS Returned Executed by Elizabeth N. Smith. Teva Women's Health, Inc. served on 6/15/2021, answer due 7/6/2021. (Kassan, Randi) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 4 Summons Issued as to All Defendants. (Attachments: #1 Summons Teva Women's Health, Inc., #2 Summons Teva Women's Health, LLC, #3 Summons Teva Branded Pharmaceutical Products R&D, Inc., #4 Summons The Cooper Companies, Inc., #5 Summons Coopersurgical, Inc.) (Rodin, Deanna) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 3 In accordance with Rule 73 of the Federal Rules of Civil Procedure and Local Rule 73.1, the parties are notified that if all parties consent a United States magistrate judge of this court is available to conduct all proceedings in this civil action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to the Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form may also be accessed at the following link: #http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO085.pdf. You may withhold your consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. (Rodin, Deanna) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (Rodin, Deanna) [Transferred from New York Eastern on 6/28/2021.] |
| Case Assigned to Judge Denis R. Hurley and Magistrate Judge James M. Wicks. Please download and review the Individual Practices of the assigned Judges, located on our #website. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. (Rodin, Deanna) [Transferred from New York Eastern on 6/28/2021.] |
| Filing 1 COMPLAINT against CooperSurgical, Inc., Teva Branded Pharmaceutical Products R&D, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc. d/b/a Teva Women's Health, LLC, Teva Women's Health, LLC, The Cooper Companies, Inc. filing fee $ 402, receipt number ANYEDC-14542023 Was the Disclosure Statement on Civil Cover Sheet completed -Yes,, filed by Elizabeth N. Smith. (Attachments: #1 Civil Cover Sheet, #2 Proposed Summons Coopersurgical, Inc., #3 Proposed Summons Teva Branded Pharmaceutical Products R&D, Inc., #4 Proposed Summons The Cooper Companies, Inc., #5 Proposed Summons Teva Pharmaceuticals USA, Inc., #6 Proposed Summons Teva Women's Health, Inc. d/b/a Teva Women's Health, LLC, #7 Proposed Summons Teva Women's Health, LLC) (Kassan, Randi) [Transferred from New York Eastern on 6/28/2021.] |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
